|
| 35948396 | Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study. | J Neurol Neurosurg Psychiatry | 2023 |
| 37966285 | Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease. | N Engl J Med | 2023 |
| 37843849 | Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. | JAMA Neurol | 2023 |
| 37942088 | Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. | Brain Commun | 2023 |
| 37680671 | Neuroimaging, clinical and life course correlates of normal-appearing white matter integrity in 70-year-olds. | Brain Commun | 2023 |
| 35362200 | Biomarker clustering in autosomal dominant Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37291760 | Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. | Aging Cell | 2023 |
| 37248905 | Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process. | J Alzheimers Dis | 2023 |
| 37280119 | Clinical considerations in early-onset cerebral amyloid angiopathy. | Brain | 2023 |
| 37463598 | Preparing for disease-modifying therapies in Alzheimer's disease. | Lancet Neurol | 2023 |
| 37231491 | Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir study. | Alzheimers Res Ther | 2023 |
| 37201176 | Operationalizing the centiloid scale for [<sup>18</sup>F]florbetapir PET studies on PET/MRI. | Alzheimers Dement (Amst) | 2023 |
| 37429916 | Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). | Nat Neurosci | 2023 |
| 36625756 | Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease. | Brain | 2023 |
| 36522155 | First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study. | J Neurol Neurosurg Psychiatry | 2023 |
| 36852663 | Acceptability and feasibility of plasma phosphorylated-tau181 in two memory services. | Int J Geriatr Psychiatry | 2023 |
| 36576155 | Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. | Alzheimers Dement | 2023 |
| 36681438 | Lecanemab slows Alzheimer's disease: hope and challenges. | Lancet Neurol | 2023 |
| 36229194 | Q351R <i>MAPT</i> mutation is associated with a mixed 3R/4R tauopathy and a slowly progressive cognitive, behavioural and parkinsonian syndrome. | J Neurol Neurosurg Psychiatry | 2023 |
| 34292397 | Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis. | J Neurol | 2022 |
| 35410910 | Associations of β-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort. | Neurology | 2022 |
| 35379992 | New insights into the genetic etiology of Alzheimer's disease and related dementias. | Nat Genet | 2022 |
| 35839659 | The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow. | Neuroimage Clin | 2022 |
| 35405027 | Combining navigator and optical prospective motion correction for high-quality 500 μm resolution quantitative multi-parameter mapping at 7T. | Magn Reson Med | 2022 |
| 35580594 | Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology. | Brain | 2022 |
| 35573283 | Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint. | Front Neurosci | 2022 |
| 35365805 | Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset. | Mol Psychiatry | 2022 |
| 35783127 | Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. | Front Aging Neurosci | 2022 |
| 35659709 | Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies. | Mol Neurodegener | 2022 |
| 35595200 | Association between carotid atherosclerosis and brain activation patterns during the Stroop task in older adults: An fNIRS investigation. | Neuroimage | 2022 |
| 35360155 | Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities. | Front Neurosci | 2022 |
| 36687397 | The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue. | Brain Commun | 2022 |
| 36411364 | Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease. | Nat Genet | 2022 |
| 36102775 | Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study. | Lancet Healthy Longev | 2022 |
| 35964185 | Straight and Divergent Pathways to Cognitive State: Seven Decades of Follow-Up in the British 1946 Birth Cohort. | J Alzheimers Dis | 2022 |
| 36189728 | Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network. | Ann Clin Transl Neurol | 2022 |
| 36151869 | Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. | Ann Neurol | 2022 |
| 35183802 | Sex-related differences in whole brain volumes at age 70 in association with hyperglycemia during adult life. | Neurobiol Aging | 2022 |
| 34854530 | Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. | Alzheimers Dement | 2022 |
| 35065037 | Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. | Lancet Neurol | 2022 |
| 35301255 | CSF biomarkers for dementia. | Pract Neurol | 2022 |
| 35137414 | Amyloid processing in COVID-19-associated neurological syndromes. | J Neurochem | 2022 |
| 34319632 | Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's disease. | Brain Pathol | 2022 |
| 30899092 | The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. | Mol Psychiatry | 2021 |
| 36097986 | Donanemab removes Alzheimer's plaques: what is special about its target? | Lancet Healthy Longev | 2021 |
| 33742656 | Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease. | Brain | 2021 |
| 33598527 | Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. | Alzheimers Dement (Amst) | 2021 |
| 33811742 | Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. | Alzheimers Dement | 2021 |
| 33694298 | A population-based study of head injury, cognitive function and pathological markers. | Ann Clin Transl Neurol | 2021 |
| 33694298 | A population-based study of head injury, cognitive function and pathological markers. | Ann Clin Transl Neurol | 2021 |